Home › GLP-1 Medications › Semaglutide
Latest three-month snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each model brings the brand up in recommendation answers.
| model | share of voice | answers |
|---|---|---|
| ChatGPT | 4% | 1 of 24 |
| Claude | 0% | 0 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 1% | 1 of 72 |
Recurring descriptions in the models' own words, grouped by theme.
“current diabetes guidance generally favors higher-weight-loss options such as semaglutide or tirzepatide when clinically appropriate.”
“**Short answer:** Saxenda can be worth it if you meet medical criteria, can tolerate a **daily injection**, and insurance makes the cost reasonable—but it is no longer usually the strongest-value GLP-1 option when weekly alternatives are covered.”
“## Compounded Tirzepatide/Semaglutide”
“** Trulicity can cause weight loss, but it is *not* FDA-approved specifically for weight management, and current ADA guidance considers semaglutide or tirzepatide generally more effective for both glucose lowering and weight loss.”
“If you have needle phobia or find the logistics of keeping injectable pens refrigerated (especially while traveling) frustrating, a pill is highly convenient.”
“Many patients turn to compounded semaglutide from accredited compounding pharmacies, which typically costs $199 to $399 per month.”
“For type 2 diabetes with overweight/obesity where **maximum weight loss** is the main priority, current ADA guidance preferentially identifies semaglutide or tirzepatide as the higher-weight-loss options.”
“- **Ozempic/semaglutide, Trulicity/dulaglutide, and Mounjaro/tirzepatide** may be preferred by insurance or have stronger glucose/weight benefits for some people, but they are usually expensive without coverage.”
“A different GLP-1—such as dulaglutide, semaglutide, exenatide, or lixisenatide—may cost less *on your specific formulary*”
“It is generally less effective than weekly semaglutide for weight loss: a head-to-head trial reported about **6.4%** mean loss with liraglutide versus **15.8%** with semaglutide 2.4 mg at 68 weeks, both alongside lifestyle counseling.”
25 exact quoted mentions in this snapshot, grouped by coded tone. Recent quotes are deduplicated and mixed across models.
“A direct 2025 comparison found tirzepatide produced greater average loss than semaglutide—20.2% vs. 13.7% at 72 weeks—though either medication can be appropriate depending on tolerability, access, and health history.”
“For people whose major goal is substantial weight loss, current ADA guidance favors more weight-effective options—particularly semaglutide or tirzepatide—when appropriate and covered.”
“It has also outperformed semaglutide in a head-to-head 72-week obesity trial.”
“ADA notes that tirzepatide and semaglutide generally have greater glucose- and weight-lowering efficacy than dulaglutide.”
“Trulicity can cause weight loss, but it is *not* FDA-approved specifically for weight management, and current ADA guidance considers semaglutide or tirzepatide generally more effective for both glucose lowering and weight loss.”
“in one 40-week comparison with semaglutide 1 mg, Mounjaro 15 mg lowered A1C by 2.3 points and body weight by 11.2 kg on average.”
“**Semaglutide (Wegovy):** Yields an average of **~15%** weight loss.”
“Many patients turn to compounded semaglutide from accredited compounding pharmacies, which typically costs $199 to $399 per month.”
“Some providers advertise compounded tirzepatide starting even lower, around $125–$249/month, and compounded semaglutide often starting around $99–$199/month.”
“**Ozempic/semaglutide, Trulicity/dulaglutide, and Mounjaro/tirzepatide** may be preferred by insurance or have stronger glucose/weight benefits for some people, but they are usually expensive without coverage.”
“FDA says tirzepatide and semaglutide are no longer on its shortage list, and it has raised concerns about fraudulent products, dose errors, and adverse-event reports involving compounded GLP-1 drugs.”
“Avoid assuming compounded "semaglutide" is an equivalent bargain”
“Some telehealth services offer compounded semaglutide at lower prices (e.g., a formulation that contains the same active ingredient, offered by some providers for around $279 per month), but note that compounded semaglutide is not FDA-appro”
Which competitors models suggest when shoppers ask for something cheaper.
2 of 25 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|---|
| appliedclinicaltrialsonline.com | 1 |
| formblends.com | 1 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.